Centro Andaluz de Biología del Desarrollo (CABD)
Ikerketa zentroak
Hospital Universitario de Salamanca
Salamanca, EspañaHospital Universitario de Salamanca -ko ikertzaileekin lankidetzan egindako argitalpenak (9)
2022
-
Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM)
Leukemia and Lymphoma, Vol. 63, Núm. 14, pp. 3438-3447
2020
-
Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: Study protocol for the prospective multicentre OptimBioma study
BMJ Open, Vol. 10, Núm. 7
-
Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)
Frontiers in Immunology
2019
-
Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus
Frontiers in Immunology, Vol. 10, Núm. JUN
-
VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes
Scientific Reports, Vol. 9, Núm. 1
2018
-
Generation and characterization of antibodies against opioid receptors from zebrafish
International Journal of Molecular Sciences, Vol. 19, Núm. 1